ADT:ADT

2 trials

Sponsors

Fudan University Shanghai Cancer Center, Peking University First Hospital

Conditions

Prostate cancerprostate cancer

Early Phase 1

CTCs in predicting oligometastatic hormone-sensitive prostate cancer patients treatment response and prognosis

Active, not recruitingChiCTR2000035857

Fudan University Shanghai Cancer CenterProstate cancer

Start: 2020-09-01Updated: 2020-08-24

Phase 3

Definitive Radiotherapy plus ADT versus ADT for Oligometastatic Prostate Cancer-nonrandomized control study

RecruitingChiCTR-OIN-17013470

Peking University First Hospitalprostate cancer

Start: 2017-11-16Updated: 2017-11-27